|
1
|
Ranganathan P, Weaver KL and Capobianco
AJ: Notch signalling in solid tumours: a little bit of everything
but not all the time. Nat Rev Cancer. 11:338–351. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhou L, Wang DS, Li QJ, Sun W, Zhang Y and
Dou KF: The down-regulation of Notch1 inhibits the invasion and
migration of hepatocellular carcinoma cells by inactivating the
cyclo-oxygenase-2/Snail/E-cadherin pathway in vitro. Dig Dis Sci.
58:1016–1025. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lim SO, Park YM, Kim HS, et al: Notch1
differentially regulates oncogenesis by wildtype p53 overexpression
and p53 mutation in grade III hepatocellular carcinoma. Hepatology.
53:1352–1362. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu M, Lee DF, Chen CT, et al: IKKalpha
activation of NOTCH links tumorigenesis via FOXA2 suppression. Mol
Cell. 45:171–184. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qi R, An H, Yu Y, et al: Notch1 signaling
inhibits growth of human hepatocellular carcinoma through induction
of cell cycle arrest and apoptosis. Cancer Res. 63:8323–8329.
2003.PubMed/NCBI
|
|
6
|
Viatour P, Ehmer U, Saddic LA, et al:
Notch signaling inhibits hepatocellular carcinoma following
inactivation of the RB pathway. J Exp Med. 208:1963–1976. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zong Y, Panikkar A, Xu J, et al: Notch
signaling controls liver development by regulating biliary
differentiation. Development. 136:1727–1739. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mazzone M, Selfors LM, Albeck J, et al:
Dose-dependent induction of distinct phenotypic responses to Notch
pathway activation in mammary epithelial cells. Proc Natl Acad Sci
USA. 107:5012–5017. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
D’Souza B, Meloty-Kapella L and Weinmaster
G: Canonical and non-canonical Notch ligands. Curr Top Dev Biol.
92:73–129. 2010.
|
|
10
|
Artavanis-Tsakonas S and Muskavitch MA:
Notch: the past, the present, and the future. Curr Top Dev Biol.
92:1–29. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kovall RA and Blacklow SC: Mechanistic
insights into Notch receptor signaling from structural and
biochemical studies. Curr Top Dev Biol. 92:31–71. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Le Bras S, Loyer N and Le Borgne R: The
multiple facets of ubiquitination in the regulation of notch
signaling pathway. Traffic. 12:149–161. 2011.PubMed/NCBI
|
|
13
|
Fortini ME: Notch signaling: the core
pathway and its posttranslational regulation. Dev Cell. 16:633–647.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
De la Pompa JL and Epstein JA:
Coordinating tissue interactions: Notch signaling in cardiac
development and disease. Dev Cell. 22:244–254. 2012.PubMed/NCBI
|
|
15
|
Wang Z, Li Y, Kong D and Sarkar FH: The
role of Notch signaling pathway in epithelial-mesenchymal
transition (EMT) during development and tumor aggressiveness. Curr
Drug Targets. 11:745–751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Leong KG, Niessen K, Kulic I, et al:
Jagged1-mediated Notch activation induces epithelial-to-mesenchymal
transition through Slug-induced repression of E-cadherin. J Exp
Med. 204:2935–2948. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Santagata S, Demichelis F, Riva A, et al:
JAGGED1 expression is associated with prostate cancer metastasis
and recurrence. Cancer Res. 64:6854–6857. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Villanueva A, Alsinet C, Yanger K, et al:
Notch signaling is activated in human hepatocellular carcinoma and
induces tumor formation in mice. Gastroenterology.
143:1660–1669.e7. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen RX, Xia YH, Xue TC, Zhang H and Ye
SL: Downregulation of osteopontin inhibits metastasis of
hepatocellular carcinoma cells via a mechanism involving MMP-2 and
uPA. Oncol Rep. 25:803–808. 2011.PubMed/NCBI
|
|
20
|
Xue TC, Han D, Chen RX, et al: High
expression of CXCR7 combined with alpha fetoprotein in
hepatocellular carcinoma correlates with extra-hepatic metastasis
to lung after hepatectomy. Asian Pac J Cancer Prev. 12:657–663.
2011.PubMed/NCBI
|
|
21
|
Simon R, Mirlacher M and Sauter G:
Immunohistochemical analysis of tissue microarrays. Methods Mol
Biol. 664:113–126. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang M, Xue L, Cao Q, et al: Expression of
Notch1, Jagged1 and beta-catenin and their clinicopathological
significance in hepatocellular carcinoma. Neoplasma. 56:533–541.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lim SO, Kim HS, Quan X, et al: Notch1
binds and induces degradation of Snail in hepatocellular carcinoma.
BMC Biol. 9:832011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Andersen P, Uosaki H, Shenje LT and Kwon
C: Non-canonical Notch signaling: emerging role and mechanism.
Trends Cell Biol. 22:257–265. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang XQ, Zhang W, Lui EL, et al:
Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular
carcinoma. Int J Cancer. 131:E163–E172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou L, Wang DS, Li QJ, Sun W, Zhang Y and
Dou KF: Downregulation of the Notch signaling pathway inhibits
hepatocellular carcinoma cell invasion by inactivation of matrix
metalloproteinase-2 and -9 and vascular endothelial growth factor.
Oncol Rep. 28:874–882. 2012.
|
|
27
|
Ye QH, Qin LX, Forgues M, et al:
Predicting hepatitis B virus-positive metastatic hepatocellular
carcinomas using gene expression profiling and supervised machine
learning. Nat Med. 9:416–423. 2003. View
Article : Google Scholar
|
|
28
|
Dong QZ, Zhang XF, Zhao Y, et al:
Osteopontin promoter polymorphisms at locus −443 significantly
affect the metastasis and prognosis of human hepatocellular
carcinoma. Hepatology. 57:1024–1034. 2012.
|
